Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.28
+0.39 (1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
HRMY Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$49.80
Upside
+45.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +118.79% | Dec 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $51 → $58 | Buy | Maintains | $51 → $58 | +69.19% | Oct 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $56 → $59 | Buy | Reiterates | $56 → $59 | +72.11% | Oct 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Oct 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Oct 29, 2024 |
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +16.69% | Oct 10, 2024 |
| Mizuho | Mizuho | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +51.69% | Oct 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Oct 2, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Sep 24, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Sep 12, 2024 |
| UBS | UBS | Strong Buy Initiates $56 | Strong Buy | Initiates | $56 | +63.36% | Sep 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Aug 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Jun 25, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Jun 24, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +40.02% | Jun 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.